Technology

Why Texas Instruments Analysts Are Even More Optimistic

Chris Lange

Published: January 25, 2017 12:50 pm

Last Updated: January 12, 2020 3:32 pm

Texas Instruments Inc. (NASDAQ: TXN) reported its fourth-quarter financial results after the markets closed on Tuesday. Although the first-quarter outlook hurts, the semiconductor maker posted a win on both the top and bottom lines to close out the fourth quarter. As a result, a few analysts updated their stances on Texas Instruments.

24/7 Wall St. has included some highlights from the earnings report, as well as what analysts are saying about the stock after the fact.

The company reported diluted earnings per share (EPS) of $1.02 on revenues of $3.41 billion. The consensus estimates from Thomson Reuters had called for EPS of $0.82 on revenues of $3.32 billion. In the same period last year, the company reported EPS of $0.80 on $3.19 billion in revenues.

Jefferies took this opportunity to maintain its Buy rating and raise its price target to $88 from $82. The firm stated in its report:

Texas Instruments reported a solid beat and raise, with the revenue outlook 280 basis points above consensus, and implying 10% year-over-year growth. In Texas Instruments’ report are signals consistent with our recent move to a Neutral stance on the group, namely increasing inventory days (up 9 days to 126) and an outlook for double digit year-over-year revenue growth. We think Texas Instruments is taking share and view it as the Free cash flow and capital return benchmark – and therefore keep our Buy rating for now.

Credit Suisse chipped in too, reiterating its Outperform rating with its $95 price target. The firm detailed:

In combination, topline growth, manufacturing efficiency and OpM leverage should support an operating model of 65%/45% non-GAAP GM/OpM over time versus our CY17 EPS estimates which embed only 62.7%/40.9%. Upside to our target model would drive ~$0.40 to CY17, potential Corporate Tax Reform an additional $0.30-$0.50. We continue to see upside to $95 and solid support at $70 or 3% dividend yield.

A few other analysts weighed in on Texas Instruments as well:

• Goldman Sachs raised the price target to $65 from $61.
• Instinet has a Neutral rating and raised the price target to $70 from $60.
• Mizuho has a Neutral rating and raised its target to $75 from $68.
• UBS raised the price target to $85 from $80.
• B. Riley has a Neutral rating and raised the price target to $75.
• Baird raised the price target to $80 from $70.
• CLSA raised the price target to $77 from $70.
• Cowen raised the price target from $73 to $77.
• Deutsche Bank raised the price target to $73 from $70.
• JPMorgan raised the price target to $90 from $85.
• Morgan Stanley raised the price target from $68 to $74.
• Oppenheimer has an Outperform rating and its target rose to $90 from $80.
• RBC raised its price target to $84 from $80.

Shares of Texas Instruments were trading up 1.2% at $78.01 on Wednesday, with a 52-week trading range of $49.10 to $78.20.